Home Recalls D-0530-2023
Class II · Moderate risk Ongoing Initiated Mar 14, 2023 (3 years ago)
Pantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP Deviations: Discoloration
What was recalled
Pantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals Inc., Piscataway, NJ, 08854, By: Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahabubnagar- 509 301, India NDC 31722-713-10
Recalling firm Hetero USA Inc
NDC code 31722-713-10
Origin NJ, United States
Initiated by N/A
FDA recall number D-0530-2023
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Ongoing Mar 26, 2026
Reason Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."
Class II · Moderate risk Terminated Sep 5, 2023
Reason Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.
Class II · Moderate risk Completed Apr 7, 2023
Reason CGMP Deviations; The impacted product and lot number was inadvertently placed into saleable inventory, which does not comply with approved procedures.
Class II · Moderate risk Terminated Dec 27, 2022
Reason Lack of sterility assurance
Class II · Moderate risk Terminated Jul 25, 2022
Reason Discoloration